Price Alert

Cue Biopharma Inc. (CUE)

NASDAQ: CUE · Real-Time Price · USD

0.73

0.01 (1.59%)

At close: Oct 03, 2025, 3:59 PM

0.72

-1.87%

After-hours: Oct 03, 2025, 06:05 PM EDT

1.59% (1D)

Bid	0.7
Market Cap	56.03M
Revenue (ttm)	8.29M
Net Income (ttm)	-38.9M
EPS (ttm)	-0.51
PE Ratio (ttm)	-1.43
Forward PE	-1.63
Analyst	Buy
Dividends	n/a

Ask	0.76
Volume	142,256
Avg. Volume (20D)	262,733
Open	0.71
Previous Close	0.72
Day's Range	0.71 - 0.73
52-Week Range	0.54 - 1.99
Beta	1.55
Ex-Dividend Date	n/a

About CUE

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol CUE

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CUE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Cue Biopharma Inc. is scheduled to release its earnings on Nov 13, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

3 months ago

-1.45%

Cue Biopharma shares are trading higher after the ... Unlock content with Pro Subscription

3 months ago

+8.67%

Cue Biopharma shares are trading higher after the company announced it received FDA pre-IND feedback for CUE-401 autoimmune therapy.

News

1 month ago · zacks.com

Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates

Cue Biopharma, Inc. (CUE) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.2 per share a year ago.